Back to search

United Kingdom· GB-APID-35726211000001100

Alimemazine 30mg/5ml oral solution

A alimemazine product containing alimemazine, registered in United Kingdom by Syri Ltd. The same ATC class is registered in 9 of our 19 countries.

ATC R06AD01

Checked against NHS dm+d (United Kingdom) on

Informational only — not a medical device.

SOURCE REGISTER · GBNHS dm+d (United Kingdom)normalisedAlimemazine 30mg/5ml oral solutionATCR06AD01REGISTER NO.GB-APID-3572621100000…PACKS LISTED3CHECKEDSeptember 13, 2026

Where it is registered

Alimemazine is registered in 9 of 19 countries.

Countries holding a registration under ATC R06AD01 (alimemazine), each read from that country’s own register.

  • This record: United Kingdom, from NHS dm+d (United Kingdom)
  • 5 of them publish a price we can compare per daily dose

Alimemazine · ATC R06AD01

9 / 19 countries

  • Belgiumprice
  • Canada
  • Finlandprice
  • Franceprice
  • Icelandprice
  • Japan
  • Norwayprice
  • Sweden
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of alimemazine costs, country by country.

Normalised to the WHO defined daily dose (30 mg), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Alimemazine · price per daily dose (30 mg)

USD · FX 28 Sept 2026

  • FR France$0.25
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

NHS dm+d (United Kingdom)
Active substance
Alimemazine
Manufacturer
Syri Ltd
Country
United Kingdom (GB)
ATC code
R06AD01
ATC class
Alimemazine
Defined daily dose
30 mg, O
Reimbursed
Not published by this register
Source register
NHS dm+d (United Kingdom)
Last checked
September 13, 2026

Packs & prices · 3

  • gtin
    5055935101099
  • gtin
    05055935101099
  • gtin
    5055935103628

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

659 interactions on record for alimemazine.

Graded by severity as the source publishes them — 80 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Alimemazine · interactions on record

659 records

  • 80 severe
  • 565 moderate
  • 14 minor

Most severe, free to view

  • PapaverineA03AD01severe
  • MetoclopramideA03FA01severe
  • DolasetronA04AA04severe
  • Potassium chlorideA12BA01severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Alimemazine in 7 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All alimemazine products

Authorised across Europe · EMA

The same active substance is authorised in 6 EEA countries. Names it is sold under:

  • Spain · Variargil
  • France · Theralene
  • Iceland · Alimemazin Evolan
  • Malta · Alimemazine Thame
  • Norway · Alimemazin Evolan, Alimemazin Orifarm
  • Sweden · Alimemazin Evolan, Alimemazin Orifarm

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/e04c6846-5c2e-4034-935a-293acd346dce
GET /v1/drugs/e04c6846-5c2e-4034-935a-293acd346dce?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "apid": "35726211000001100",
  "desc": "Alimemazine 30mg/5ml oral solution (Syri Ltd)",
  "form": "Oral solution",
  "vpid": "35896911000001100",
  "source": "dmd",
  "vtm_id": "774470000",
  "strength": "6 mg",
  "substance": "Alimemazine",
  "ingredient": "Alimemazine tartrate",
  "supplier_code": "39398711000001105"
}

See everything about alimemazine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.